Headlands Research is heading to SCOPE 2026 this February!
As a multinational, integrated clinical trial site organization, we’re proud to be part of the conversations shaping the future of clinical research. With experience supporting over 5,000 clinical trials, our focus remains the same: delivering meaningful participant experiences and the highest quality data.
If you’ll be at SCOPE, we’d love to connect. Reach out to a team member to schedule a time to chat at the event:
• Kyle Burtnett, Chief Executive Officer
• Lauren Chazal, Chief Business Development Officer
• McKenzie Lang, Director of Business Development
• Ken Northrop, Site Director at Headlands Research Orlando